Skip to main content
Premium Trial:

Request an Annual Quote

Genialis: Krista McKerracher

RNA biomarker company Genialis has appointed Krista McKerracher as chairperson of the board of directors. McKerracher has held senior commercial and R&D leadership roles at Johnson & Johnson and Novartis Oncology. She has also worked for CRISPR Therapeutics, where she led the team that brought HbF edited stem cells for hemoglobinopathies to the clinic. She graduated from the University of Waterloo with a BSc in applied health sciences, and holds an MBA from York University.